Serological Immunity (Measles Immunoglobulin G) to Measles Among Newly Employed Healthcare Workers (2009–2019) by Age at Time of Employment
Age at Employment, y . | Positive . | . | Equivocal . | . | Negative . | . | Total . | P Valuea . | Odds Ratio (95% Confidence Interval) . |
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | |||
10–19 | 98 | 83.1 | 9 | 7.6 | 11 | 9.3 | 118 | < .0001 | 9.22 (3.37–25.28) |
20–29 | 4951 | 83.2 | 346 | 5.8 | 656 | 11.0 | 5953 | < .0001 | 9.15 (3.76–22.25) |
30–39 | 3223 | 86.5 | 189 | 5.1 | 315 | 8.5 | 3727 | < .0001 | 7.07 (2.90–17.23) |
40–49 | 1339 | 89.6 | 54 | 3.6 | 101 | 6.8 | 1494 | < .0001 | 5.23 (2.12–12.89) |
50–59 | 749 | 90.7 | 27 | 3.3 | 50 | 6.1 | 826 | .00013 | 4.65 (1.86–11.62) |
60+ | 226 | 97.8 | 0 | 0.0 | 5 | 2.2 | 231 | Reference group | Reference group |
Total | 10 586 | 85.7 | 625 | 5.1 | 1138 | 9.2 | 12 349 |
Age at Employment, y . | Positive . | . | Equivocal . | . | Negative . | . | Total . | P Valuea . | Odds Ratio (95% Confidence Interval) . |
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | |||
10–19 | 98 | 83.1 | 9 | 7.6 | 11 | 9.3 | 118 | < .0001 | 9.22 (3.37–25.28) |
20–29 | 4951 | 83.2 | 346 | 5.8 | 656 | 11.0 | 5953 | < .0001 | 9.15 (3.76–22.25) |
30–39 | 3223 | 86.5 | 189 | 5.1 | 315 | 8.5 | 3727 | < .0001 | 7.07 (2.90–17.23) |
40–49 | 1339 | 89.6 | 54 | 3.6 | 101 | 6.8 | 1494 | < .0001 | 5.23 (2.12–12.89) |
50–59 | 749 | 90.7 | 27 | 3.3 | 50 | 6.1 | 826 | .00013 | 4.65 (1.86–11.62) |
60+ | 226 | 97.8 | 0 | 0.0 | 5 | 2.2 | 231 | Reference group | Reference group |
Total | 10 586 | 85.7 | 625 | 5.1 | 1138 | 9.2 | 12 349 |
aComparing positive vs those with negative or equivocal titers.
Serological Immunity (Measles Immunoglobulin G) to Measles Among Newly Employed Healthcare Workers (2009–2019) by Age at Time of Employment
Age at Employment, y . | Positive . | . | Equivocal . | . | Negative . | . | Total . | P Valuea . | Odds Ratio (95% Confidence Interval) . |
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | |||
10–19 | 98 | 83.1 | 9 | 7.6 | 11 | 9.3 | 118 | < .0001 | 9.22 (3.37–25.28) |
20–29 | 4951 | 83.2 | 346 | 5.8 | 656 | 11.0 | 5953 | < .0001 | 9.15 (3.76–22.25) |
30–39 | 3223 | 86.5 | 189 | 5.1 | 315 | 8.5 | 3727 | < .0001 | 7.07 (2.90–17.23) |
40–49 | 1339 | 89.6 | 54 | 3.6 | 101 | 6.8 | 1494 | < .0001 | 5.23 (2.12–12.89) |
50–59 | 749 | 90.7 | 27 | 3.3 | 50 | 6.1 | 826 | .00013 | 4.65 (1.86–11.62) |
60+ | 226 | 97.8 | 0 | 0.0 | 5 | 2.2 | 231 | Reference group | Reference group |
Total | 10 586 | 85.7 | 625 | 5.1 | 1138 | 9.2 | 12 349 |
Age at Employment, y . | Positive . | . | Equivocal . | . | Negative . | . | Total . | P Valuea . | Odds Ratio (95% Confidence Interval) . |
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | |||
10–19 | 98 | 83.1 | 9 | 7.6 | 11 | 9.3 | 118 | < .0001 | 9.22 (3.37–25.28) |
20–29 | 4951 | 83.2 | 346 | 5.8 | 656 | 11.0 | 5953 | < .0001 | 9.15 (3.76–22.25) |
30–39 | 3223 | 86.5 | 189 | 5.1 | 315 | 8.5 | 3727 | < .0001 | 7.07 (2.90–17.23) |
40–49 | 1339 | 89.6 | 54 | 3.6 | 101 | 6.8 | 1494 | < .0001 | 5.23 (2.12–12.89) |
50–59 | 749 | 90.7 | 27 | 3.3 | 50 | 6.1 | 826 | .00013 | 4.65 (1.86–11.62) |
60+ | 226 | 97.8 | 0 | 0.0 | 5 | 2.2 | 231 | Reference group | Reference group |
Total | 10 586 | 85.7 | 625 | 5.1 | 1138 | 9.2 | 12 349 |
aComparing positive vs those with negative or equivocal titers.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.